Online citations, reference lists, and bibliographies.
← Back to Search

Overcoming The Stability, Toxicity, And Biodegradation Challenges Of Tumor Stimuli-responsive Inorganic Nanoparticles For Delivery Of Cancer Therapeutics

J. L. Paris, A. Baeza, M. Vallet-Regí
Published 2019 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT Introduction: Stimuli-responsive nanomaterials for cancer therapy have attracted much interest recently due to their potential for improving the current standard of care. Different types of inorganic nanoparticles are widely employed for the development of these strategies, but in some cases safety concerns hinder their clinical translation. This review aims to provide an overview of the challenges that inorganic nanoparticles face regarding their stability, toxicity, and biodegradability, as well as the strategies that have been proposed to overcome them. Areas covered: The available information about the in vitro and in vivo biocompatibility, as well as the biodegradability of the following nanoparticles, is presented and discussed: superparamagnetic iron oxide nanoparticles, gold nanoparticles, graphene and mesoporous nanoparticles made of silicon or silicon oxide. The toxicology of inorganic nanoparticles is greatly affected by many physicochemical parameters, and their surface modification emerges as the main intervention to improve their biocompatibility and tailor their performance for specific biomedical applications. Expert opinion: Even though many different studies have been performed regarding the biological behavior of inorganic nanoparticles, long-term in vivo data is still scarce, limiting our capacity to evaluate the proposed nanomaterials for clinical use. The role of biodegradability in different therapeutic contexts is also discussed.
This paper references
10.1016/j.nano.2015.03.004
Toxicity of silica nanoparticles depends on size, dose, and cell type.
I. Kim (2015)
10.1021/nn204229f
Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties.
Anja Schinwald (2012)
10.1039/c3nr32551b
Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles.
M. Mahmoudi (2013)
10.1021/JP971656Q
Gold Nanorods: Electrochemical Synthesis and Optical Properties
Y. Yu (1997)
10.1021/nn200365a
The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Xinglu Huang (2011)
10.1016/J.CARBON.2010.11.005
Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration
Xiaoyong Zhang (2011)
10.1007/s10853-015-9324-2
Magnetic nanoparticles: material engineering and emerging applications in lithography and biomedicine
Y. Bao (2015)
10.1021/CM902635J
Environment-Friendly Method To Produce Graphene That Employs Vitamin C and Amino Acid
J. Gao (2010)
10.1016/J.CARBON.2011.05.056
In vitro and in vivo behaviors of dextran functionalized graphene
S. Zhang (2011)
10.1002/anie.201811691
Molecular Scaffolds as Double-Targeting Agents For the Diagnosis and Treatment of Neuroblastoma.
Gonzalo Villaverde (2019)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
10.1002/PPSC.201800148
Targeted Chemo‐Photothermal Therapy: A Nanomedicine Approximation to Selective Melanoma Treatment
Gonzalo Villaverde (2018)
10.1021/nn1007176
Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells.
Yongbin Zhang (2010)
• Review which describes the use of GNP in hyperthermia treatment of tumours
10.1021/CM0492336
Seed-Mediated Synthesis of Gold Nanorods: Role of the Size and Nature of the Seed
Anand Gole and (2004)
10.1039/c0nr00478b
Surface charge of gold nanoparticles mediates mechanism of toxicity.
Nicole Schaeublin (2011)
Review which describes in detail the optical properties and clinical applications of GNP
10.3390/ma5101873
In Vivo Toxicity of Intravenously Administered Silica and Silicon Nanoparticles
S. Ivanov (2012)
10.1016/j.nano.2016.04.004
Studies of silicon nanoparticles uptake and biodegradation in cancer cells by Raman spectroscopy.
E. Tolstik (2016)
10.1038/ncomms7208
Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues
Adi Tzur-Balter (2015)
10.1088/0957-4484/21/7/075102
Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells.
B. Ankamwar (2010)
10.1021/nn100918a
In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
L. Li (2010)
10.1021/CM503004B
A Nanostopper Approach To Selectively Engineer the Surfaces of Mesoporous Silicon
Wujun Xu (2014)
10.1002/adma.201202678
Unraveling stress-induced toxicity properties of graphene oxide and the underlying mechanism.
Wendi Zhang (2012)
10.1016/j.toxlet.2010.11.016
In vitro toxicity evaluation of graphene oxide on A549 cells.
Yanli Chang (2011)
10.1038/s41467-018-06730-z
Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics
Prashant Dogra (2018)
10.1021/am200428v
Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts.
Ken-Hsuan Liao (2011)
10.1021/nn1002387
Reducing sugar: new functional molecules for the green synthesis of graphene nanosheets.
C. Zhu (2010)
10.1021/am5082793
Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
N. Han (2015)
Review on the preparation and biomedical applications of MSiNs
10.1021/ja508721y
Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine.
Y. Chen (2014)
10.1016/j.addr.2016.05.015
Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy.
K. Yang (2016)
10.1002/jbm.a.35017
Degradation and biocompatibility of multistage nanovectors in physiological systems.
J. Martinez (2014)
10.1021/ja910846q
Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
Yu-Shen Lin (2010)
10.1002/smll.200900466
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
10.1016/j.jcis.2018.03.008
The combined magnetic field and iron oxide-PLGA composite particles: Effective protein antigen delivery and immune stimulation in dendritic cells.
Chalathan Saengruengrit (2018)
10.1016/J.APMT.2016.04.003
Thickness of functionalized graphene oxide sheets plays critical role in tissue accumulation and urinary excretion: A pilot PET/CT study
Dhifaf A Jasim (2016)
10.1002/adma.201101586
Bioceramics: from bone regeneration to cancer nanomedicine.
M. Vallet-Regí (2011)
•• Review on the biomedical applications of graphene
• Review which describes the toxicity of graphene and related nanostructures
10.1016/j.jconrel.2007.12.017
A review of stimuli-responsive nanocarriers for drug and gene delivery.
Srinivas Ganta (2008)
10.1021/nn300172t
Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications.
S. Singh (2012)
10.5772/58290
Characterization and Comparison of Mesoporous Silica Particles for Optimized Drug Delivery
X. Huang (2014)
10.1021/nn2021088
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.
M. Mahmoudi (2011)
10.1002/smll.200800926
Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells.
I. Slowing (2009)
10.1021/mp200611d
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.
Mirkka Sarparanta (2012)
10.1021/ACS.CHEMMATER.9B00221
Degradable Drug Carriers: Vanishing Mesoporous Silica Nanoparticles
Karin Moller (2019)
10.1002/marc.201300868
Poly(methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization.
M. Shahbazi (2014)
10.1039/C5TB00304K
Mesoporous silica nanoparticles grafted with a light-responsive protein shell for highly cytotoxic antitumoral therapy.
M. Martínez-Carmona (2015)
10.1080/19430892.2011.633479
Cytotoxicity and Cellular Internalization Studies of Biogenic Gold Nanotriangles in Animal Cell Lines
A. Singh (2011)
10.1186/s12989-016-0168-y
Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms
Lingling Ou (2016)
10.2147/IJN.S42047
Green synthesis of graphene and its cytotoxic effects in human breast cancer cells
S. Gurunathan (2013)
10.1002/smll.200901680
Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.
L. Zhang (2010)
10.1016/j.ijbiomac.2016.01.116
Safety and biocompatibility of graphene: A new generation nanomaterial for biomedical application.
S. Syama (2016)
10.1002/jbm.a.35491
Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars.
P. Favi (2015)
10.1016/j.jconrel.2016.02.015
Assessing biocompatibility of graphene oxide-based nanocarriers: A review.
Siaw Fui Kiew (2016)
10.1021/CM3001688
Preparation of Colloidal Mesoporous Silica Nanoparticles with Different Diameters and Their Unique Degradation Behavior in Static Aqueous Systems
Hironori Yamada (2012)
10.1007/s12274-015-0715-0
Oligonucleotide delivery by chitosan-functionalized porous silicon nanoparticles
Morteza Hasanzadeh Kafshgari (2015)
10.1186/s12951-018-0403-9
Recent advancements in the use of exosomes as drug delivery systems
E. J. Bunggulawa (2018)
10.1021/ja201779d
Aqueous colloidal mesoporous nanoparticles with ethenylene-bridged silsesquioxane frameworks.
Chihiro Urata (2011)
10.1039/c7cs00657h
Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
Y. Hu (2018)
10.1016/j.biomaterials.2013.01.010
Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer.
W. Miao (2013)
10.1021/ac202115a
On-chip evaluation of shear stress effect on cytotoxicity of mesoporous silica nanoparticles.
Donghyuk Kim (2011)
10.1002/jbm.a.32807
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.
B. Godin (2010)
Review which describes the synthesis, characteristics and clinical application of SPION
10.1039/c5nr06122a
Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery.
S. Heidegger (2016)
10.1021/acs.molpharmaceut.6b00405
Iron Oxide Nanoparticles Induce Autophagosome Accumulation through Multiple Mechanisms: Lysosome Impairment, Mitochondrial Damage, and ER Stress.
X. Zhang (2016)
10.1016/j.biomaterials.2008.07.007
The biocompatibility of mesoporous silicates.
S. Hudson (2008)
10.1016/J.COLSURFA.2007.04.078
Poly(D,L-lactide-co-glycolide) coated superparamagnetic iron oxide nanoparticles : Synthesis, characterization and in vivo study as MRI contrast agent
D. Patel (2008)
10.1021/nl100996u
Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy.
K. Yang (2010)
10.1039/C2TB00025C
Biopolymer functionalized reduced graphene oxide with enhanced biocompatibility via mussel inspired coatings/anchors.
Chong Cheng (2013)
10.1021/nn202355p
Successful stabilization of graphene oxide in electrolyte solutions: enhancement of biofunctionalization and cellular uptake.
B. Hong (2012)
10.3390/ijms17010054
Effects of Iron-Oxide Nanoparticle Surface Chemistry on Uptake Kinetics and Cytotoxicity in CHO-K1 Cells
Camille C. Hanot (2015)
Review on stimuli-responsive MSNs for drug delivery
Biomedical applications of graphene. Theranostics
H Shen (2012)
10.1016/j.biomaterials.2014.03.021
The in vitro and in vivo toxicity of graphene quantum dots.
Yu Chong (2014)
10.1021/NL052396O
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.
B. Chithrani (2006)
10.1039/C8NR00693H
Mesoporous silica nanoparticles engineered for ultrasound-induced uptake by cancer cells.
J. Paris (2018)
10.1016/j.jconrel.2014.01.003
Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
Huiyuan Hou (2014)
10.1007/S12274-008-8021-8
Nano-graphene oxide for cellular imaging and drug delivery
X. Sun (2008)
10.1038/s41598-018-19628-z
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
Qiyi Feng (2018)
10.2147/IJN.S39534
The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice
Soyoung Lee (2013)
10.1523/JNEUROSCI.6054-09.2010
Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity
H. Kim (2010)
10.1021/acsami.8b02398
Beyond Traditional Hyperthermia: In Vivo Cancer Treatment with Magnetic-Responsive Mesoporous Silica Nanocarriers.
E. Guisasola (2018)
10.1016/j.addr.2012.10.002
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.
H. Maeda (2013)
10.1016/J.MICROMESO.2010.01.009
The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid
Q. He (2010)
10.1016/j.biomaterials.2012.01.029
The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems.
Mirkka Sarparanta (2012)
10.3109/17435390903471463
Gold nanoparticles cellular toxicity and recovery: Effect of size, concentration and exposure time
T. Mironava (2010)
10.1021/jacs.6b04299
"Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
Luodan Yu (2016)
10.3109/10408440903453074
A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity
H. Johnston (2010)
10.2217/nnm.10.158
Graphene in biomedicine: opportunities and challenges.
L. Feng (2011)
10.2217/nnm-2016-0248
Drug-loaded liposome-capped mesoporous core-shell magnetic nanoparticles for cellular toxicity study.
M. E. Sharifabad (2016)
10.1021/ja2010175
Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy.
J. Robinson (2011)
10.1002/adma.201505524
Large Pore-Sized Hollow Mesoporous Organosilica for Redox-Responsive Gene Delivery and Synergistic Cancer Chemotherapy.
M. Wu (2016)
10.1002/jbm.a.34294
Tailoring the biodegradability of porous silicon nanoparticles.
N. K. Hon (2012)
10.1021/LA0520029
Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity.
H. Takahashi (2006)
10.1002/SMTD.201800007
Heating at the Nanoscale through Drug‐Delivery Devices: Fabrication and Synergic Effects in Cancer Treatment with Nanoparticles
Eduardo Guisasola (2018)
10.1039/C6RA07763C
Selective topotecan delivery to cancer cells by targeted pH-sensitive mesoporous silica nanoparticles
Marina Martínez-Carmona (2016)
10.1166/JBN.2011.1224
Toxicity of graphene in normal human lung cells (BEAS-2B).
N. V. S. Vallabani (2011)
10.1021/ja803688x
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs.
Zhuang Liu (2008)
10.1002/smll.201102393
Hemocompatibility and macrophage response of pristine and functionalized graphene.
A. Sasidharan (2012)
10.1007/s11671-010-9751-6
Biocompatibility of Graphene Oxide
K. Wang (2011)
10.1021/nl404316v
Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres.
D. Shen (2014)
10.1021/acsnano.7b04495
In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles.
Oshra Betzer (2017)
10.1021/acs.langmuir.7b01316
A Facile Strategy to Prepare an Enzyme-Responsive Mussel Mimetic Coating for Drug Delivery Based on Mesoporous Silica Nanoparticles.
Chunlin Hu (2017)
10.1021/nn2043803
Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold.
T. Yu (2012)
10.1126/scitranslmed.3001963
The Fate and Toxicity of Raman-Active Silica-Gold Nanoparticles in Mice
A. Thakor (2011)
10.1039/b806051g
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity.
Elodie Boisselier (2009)
10.1002/ANIE.200504277
Colorimetric screening of DNA-binding molecules with gold nanoparticle probes.
Min Su Han (2006)
10.1002/SMLL.200700378
Size-dependent cytotoxicity of gold nanoparticles.
Y. Pan (2007)
10.1002/adma.201604634
Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles.
Jonas G. Croissant (2017)
10.1016/J.MICROMESO.2006.12.048
Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior
Xia Li (2007)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.1002/adma.201601498
Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization.
S. Wang (2016)
10.1021/acs.nanolett.6b04269
Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species.
Ping'an Ma (2017)
10.1021/ACS.CHEMMATER.7B03128
Multifunctional Protocells for Enhanced Penetration in 3D Extracellular Tumoral Matrices.
M. R. Villegas (2018)
10.1016/j.jneumeth.2016.09.003
A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells
Maria A. Gonzalez Porras (2016)
10.1021/acs.molpharmaceut.7b00519
Lipid Bilayer-Gated Mesoporous Silica Nanocarriers for Tumor-Targeted Delivery of Zoledronic Acid in Vivo.
D. Desai (2017)
10.1016/j.nano.2015.07.004
Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape.
L. Li (2015)
10.1039/C0JM01390K
Impact of different PEGylation patterns on the long-term bio-stability of colloidal mesoporous silica nanoparticles
V. Cauda (2010)
10.1021/ACS.CHEMMATER.6B03905
Cellular Organelle-Dependent Cytotoxicity of Iron Oxide Nanoparticles and Its Implications for Cancer Diagnosis and Treatment: A Mechanistic Investigation
Chieh-Cheng Huang (2016)
10.1186/1556-276X-9-656
Chemical and magnetic functionalization of graphene oxide as a route to enhance its biocompatibility
K. Urbaś (2014)
10.1016/j.biomaterials.2012.12.043
The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes.
Changhui Fu (2013)
10.1002/smll.201201417
Behavior and toxicity of graphene and its functionalized derivatives in biological systems.
K. Yang (2013)
10.1007/s00204-017-1993-y
Toxicology of silica nanoparticles: an update
S. Murugadoss (2017)
10.1021/nn2007496
Effect of gold nanoparticle aggregation on cell uptake and toxicity.
Alexandre Albanese (2011)
10.1038/nnano.2007.149
Bacteria-mediated delivery of nanoparticles and cargo into cells.
D. Akin (2007)
10.1007/s11596-018-1989-8
Biodistribution and Toxicity Assessment of Superparamagnetic Iron Oxide Nanoparticles In Vitro and In Vivo
Q. Yu (2018)
10.1021/acsami.5b07116
Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues.
M. R. Villegas (2015)
10.1517/17425247.2014.953051
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
A. Baeza (2015)
10.1371/journal.pone.0085835
Toxicity Assessment of Silica Coated Iron Oxide Nanoparticles and Biocompatibility Improvement by Surface Engineering
M. A. Malvindi (2014)
10.1021/ar3000986
Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Derrick Tarn (2013)
10.1080/17435390.2016.1264638
Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity
K. Choi (2017)
10.1021/tx400385x
Nanotoxicity of graphene and graphene oxide.
Amedea B. Seabra (2014)
10.1088/0957-4484/21/14/145101
In vitro toxicity studies of polymer-coated gold nanorods.
R. G. Rayavarapu (2010)
10.1002/smll.201502119
Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.
K. Butler (2016)
10.1166/JNN.2012.6199
In vitro degradation behavior of silica nanoparticles under physiological conditions.
Nanjing Hao (2012)
10.1016/J.CEJ.2017.12.051
Ultrasound-mediated cavitation-enhanced extravasation of mesoporous silica nanoparticles for controlled-release drug delivery
J. Paris (2017)
10.1021/CM402592T
Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
C. Argyo (2014)
10.1021/acsnano.5b04378
Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.
J. Paris (2015)
10.1016/j.addr.2009.11.008
Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
B. Fadeel (2010)
10.1039/c5nr07887c
Therapeutic application of anti-angiogenic nanomaterials in cancers.
S. Mukherjee (2016)
10.1002/jat.3187
Accumulation and toxicity of intravenously‐injected functionalized graphene oxide in mice
Kai-ping Wen (2015)
10.1016/j.jconrel.2018.09.031
Nano‐targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo
D. F. Mardhian (2018)
10.7150/thno.3642
Biomedical Applications of Graphene
H. Shen (2012)
10.2217/nnm.13.223
Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.
H. Santos (2014)
10.1016/j.taap.2011.03.011
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells.
A. Kunzmann (2011)
10.1158/1078-0432.CCR-16-1297
First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas
S. Bonvalot (2016)
10.1039/C5TB00287G
A new targeting agent for the selective drug delivery of nanocarriers for treating neuroblastoma.
Gonzalo Villaverde (2015)
10.1002/adfm.201707030
Protoporphyrin IX (PpIX)-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters for Magnetic Resonance Imaging and Photodynamic Therapy.
Lesan Yan (2018)
10.1002/ADFM.201302988
Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer‐Targeted Drug Delivery In Vivo
Q. Zhang (2014)
10.1039/c0cc05005a
Biocompatible reduced graphene oxide prepared by using dextran as a multifunctional reducing agent.
Y. Kim (2011)
10.1016/j.biomaterials.2013.10.065
Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake.
Chang-Fang Wang (2014)
10.1103/PHYSREVE.92.023019
Ultrasound-induced inertial cavitation from gas-stabilizing nanoparticles.
J. Kwan (2015)
10.1007/s11051-012-1320-8
Recent advances in graphene family materials toxicity investigations
A. Jastrzębska (2012)
10.1016/j.biomaterials.2010.10.035
Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice.
Tianlong Liu (2011)
Encapsulation of VEGF 165 into magnetic PLGA nanocapsules for potential local delivery and bioactivity in human brain endothelial cells
E. Carenza (2015)
10.1039/c5nr09112h
Breakable mesoporous silica nanoparticles for targeted drug delivery.
L. Maggini (2016)
10.1088/0957-4484/23/41/415101
Cellular imaging using biocompatible dendrimer-functionalized graphene oxide-based fluorescent probe anchored with magnetic nanoparticles.
Prateek S. Wate (2012)
10.1016/J.MICROMESO.2009.11.015
Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol)
V. Cauda (2010)
10.1039/c7nr05050j
A novel visible light responsive nanosystem for cancer treatment.
M. Martínez-Carmona (2017)
10.1021/la302446h
Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo.
Angéla Jedlovszky-Hajdú (2012)
10.1021/ac702037y
Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells.
C. Medley (2008)
10.1016/j.bioorg.2017.12.033
Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
H. Nosrati (2018)
10.1021/CM0011559
A New Property of MCM-41: Drug Delivery System
M. Vallet-Regí (2001)
10.1016/j.biomaterials.2013.07.049
Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics.
J. Martinez (2013)
10.1039/c4nr05061d
Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice.
L. Yang (2015)
10.1021/JA028110O
Photochemical synthesis of gold nanorods.
F. Kim (2002)
10.18433/J31021
Nanotoxicity of Inert Materials: The Case of Gold, Silver and Iron.
M. Umair (2016)
10.1039/C5TB00300H
Silica-coated super-paramagnetic iron oxide nanoparticles (SPIONPs): a new type contrast agent of T1 magnetic resonance imaging (MRI).
M. Iqbal (2015)
10.3402/nano.v1i0.5358
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
N. Singh (2010)
10.1016/j.addr.2009.03.007
Magnetic nanoparticles for theragnostics.
V. Shubayev (2009)
10.1002/smll.201402145
Gold nanorods coated with mesoporous silica shell as drug delivery system for remote near infrared light-activated release and potential phototherapy.
Ji Liu (2015)
10.1021/CM302142K
Chemical Modification As a Versatile Tool for Tuning Stability of Silica Based Mesoporous Carriers in Biologically Relevant Conditions
Thomas Fontecave (2012)
10.1021/acs.langmuir.5b03470
Magnetic-Responsive Release Controlled by Hot Spot Effect.
E. Guisasola (2015)
10.1016/j.bbrc.2010.02.046
Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice.
C. Lasagna-Reeves (2010)
10.1039/c0cc02923h
Stability of small mesoporous silica nanoparticles in biological media.
Yu-Shen Lin (2011)
10.1016/j.biomaterials.2013.01.001
In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration.
K. Yang (2013)
10.3390/ijms161024417
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles
U. Patil (2015)
10.1002/adma.201604894
Light-Triggered Assembly of Gold Nanoparticles for Photothermal Therapy and Photoacoustic Imaging of Tumors In Vivo.
Xiaju Cheng (2017)
10.1021/nl204388p
Graphite nanoplatelets and Caenorhabditis elegans: insights from an in vivo model.
E. Zanni (2012)
10.1007/s10971-016-4053-9
Dissolution kinetics of mesoporous silica nanoparticles in different simulated body fluids
Katharina Braun (2016)
10.1016/J.BIOMATERIALS.2006.12.003
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro.
K. Mueller (2007)
10.1016/j.biomaterials.2011.12.010
Multi-functional graphene as an in vitro and in vivo imaging probe.
Ganesh Gollavelli (2012)
10.1021/acsnano.9b00241
Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment
P. Mora-Raimundo (2019)
10.1007/s10853-017-0787-1
Tuning mesoporous silica dissolution in physiological environments: a review
J. L. Paris (2017)
10.1021/CM203000U
Magnetically Triggered Multidrug Release by Hybrid Mesoporous Silica Nanoparticles
A. Baeza (2012)
10.1002/adhm.201200022
Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.
Katharine E. Epler (2012)
10.1016/j.biomaterials.2013.06.052
The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility.
M. Shahbazi (2013)
10.1038/nmat2398
Biodegradable luminescent porous silicon nanoparticles for in vivo applications.
J. Park (2009)
10.1021/nl5045378
In vivo analysis of biodegradable liposome gold nanoparticles as efficient agents for photothermal therapy of cancer.
A. Rengan (2015)
10.1021/am403380e
Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo.
Bing Xia (2013)
10.1016/S1470-2045(18)30332-2
Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial
P. Lyon (2018)
10.1016/S0891-5849(02)00772-4
Molecular bases of cellular iron toxicity.
J. Eaton (2002)
10.1002/smll.201001459
In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
Q. He (2011)
10.1021/acsnano.6b00539
Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.
M. Xu (2016)
10.1016/j.jconrel.2011.09.098
The journey of a drug-carrier in the body: an anatomo-physiological perspective.
N. Bertrand (2012)
10.1021/tx300129f
Can graphene oxide cause damage to eyesight?
L. Yan (2012)
10.1021/ac400242w
Single cell array based assay for in vitro genotoxicity study of nanomaterials.
Y. Qiao (2013)
10.1016/j.jconrel.2014.05.036
State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines.
Charlene M. Dawidczyk (2014)
Review which describes in detail the synthesis and principal uses in the clinical field of SPION
10.1002/SMLL.200700217
Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells.
Tanya S. Hauck (2008)
10.1039/C4TB01895H
Encapsulation of VEGF165 into magnetic PLGA nanocapsules for potential local delivery and bioactivity in human brain endothelial cells.
E. Carenza (2015)
10.2217/NNM-2016-0311
Exploitation of functional nanomaterials in therapy and diagnostics.
Tapas Sen (2016)
10.1021/nn204102q
Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.
C. Ashley (2012)
10.1038/nnano.2015.111
In vivo integrity of polymer-coated gold nanoparticles.
W. Kreyling (2015)
10.1016/j.nano.2012.06.002
In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles.
Carrie A. Simpson (2013)
10.1080/17425247.2016.1229298
Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks
A. Baeza (2017)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
• Review which describes the principal mechanisms of toxicity caused by SPION
Review which describes the degradability and clearance of silicon and silica nanoparticles
Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar